Sun Hai-yun, Cai Jun, Pang Hong-yu, Hei Zi-qing, Li Shang-rong
Department of Anesthesiology, Third Affiliated Hospital, Zhongshan University, Guangzhou 510630, Guangdong, China.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009 Feb;21(2):89-91.
To observe the changes in plasma S-100 beta and neuron-specific enolase (NSE) and to study their relationship with encephalopathy after orthotopic liver transplantation (OLT).
Thirty patients without neurological disease undergoing OLT were studied. Plasma S-100 beta and NSE were examined at three time points: after induction of anesthesia (T1), at the end of operation (T2) and 24 hours after reperfusion of the transplant (T3). The difference of plasma S-100 beta and NSE between encephalopathy group and non-encephalopathy group was analyzed.
Eleven patients were complicated with encephalopathy after OLT. In 30 patients, S-100 beta at T2 [(3.715+/-1.523) microg/L] was higher than that at T1 [(1.478+/-0.809) microg/L, P<0.01]; S-100 beta at T3 [(1.765+/-0.894) microg/L] decreased to normal level (T1). NSE at T2 [(26.684+/-7.973) microg/L] was higher than that at T1 [(14.012+/-4.612) microg/L, P<0.01]. At T3, the level of plasma NSE [(18.105+/-7.345) microg/L] was decreased, but higher than that at T1. Plasma S-100 beta and NSE in encephalopathy group (11 cases) and non-encephalopathy group (19 cases) showed the same tendency of change as all of the patients. Plasma S-100 beta at T3 in encephalopathy group [(2.007+/-0.854)microg/L] was higher than that in non-encephalopathy group [(1.468+/-0.903) microg/L, P<0.05], and it was correlated with the presence of encephalopathy (r=0.385, P=0.039), but not at T1 and T2. Plasma NSE at three time points showed no relationship to the presence of encephalopathy.
The increase in plasma S-100 beta and NSE during OLT indicates the occurrence of damage to the brain. But plasma S-100 beta and NSE cannot predict encephalopathy after OLT.
观察原位肝移植(OLT)后血浆S-100β和神经元特异性烯醇化酶(NSE)的变化,并研究它们与肝移植后脑病的关系。
研究30例接受OLT且无神经系统疾病的患者。在三个时间点检测血浆S-100β和NSE:麻醉诱导后(T1)、手术结束时(T2)和移植肝再灌注后24小时(T3)。分析脑病组和非脑病组血浆S-100β和NSE的差异。
11例患者OLT后并发脑病。30例患者中,T2时S-100β[(3.715±1.523)μg/L]高于T1时[(1.478±0.809)μg/L,P<0.01];T3时S-100β[(1.765±0.894)μg/L]降至正常水平(T1时)。T2时NSE[(26.684±7.973)μg/L]高于T1时[(14.012±4.612)μg/L,P<0.01]。T3时,血浆NSE水平[(18.105±7.345)μg/L]下降,但高于T1时。脑病组(11例)和非脑病组(19例)血浆S-100β和NSE的变化趋势与所有患者相同。脑病组T3时血浆S-100β[(2.007±0.854)μg/L]高于非脑病组[(1.468±0.903)μg/L,P<0.05],且与脑病的发生相关(r=0.385,P=0.039),但在T1和T2时无相关性。三个时间点的血浆NSE与脑病的发生无关。
OLT期间血浆S-100β和NSE升高表明脑损伤的发生。但血浆S-100β和NSE不能预测OLT后脑病的发生。